品牌分类
品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
商品描述
RecombinantHumanIL-6(HEK293-expressed)ProteinSummary
| DetailsofFunctionality | MeasuredinacellproliferationassayusingT1165.85.2.1mouseplasmacytomacells.Nordan,R.P.et al.(1987)J.Immunol.139:813.TheED50forthiseffectis0.1-0.6ng/mL. |
| Source | Humanembryonickidneycell,HEK293-derivedhumanIL-6proteinMet1-Met212 |
| Accession# | P05231 |
| N-terminalSequence | Ala28&Val30 |
| Protein/PeptideType | RecombinantProteins |
| Gene | IL6 |
| Purity | >95%,bySDS-PAGEvisualizedwithSilverStainingandquantitativedensitometrybyCoomassie®BlueStaining. |
| EndotoxinNote | <0.10 eu="" per="" 1="" μg="" of="" the="" protein="" by="" the="" lal="">0.10> |
Applications/Dilutions
| TheoreticalMW | 20.8kDa.Disclaimernote:Theobservedmolecularweightoftheproteinmayvaryfromthelistedpredictedmolecularweightduetoposttranslationalmodifications,posttranslationcleavages,relativecharges,andotherexperimentalfactors. |
| SDS-PAGE | 22kDa,reducingconditions |
Packaging,Storage&Formulations
| Storage | Useamanualdefrostfreezerandavoidrepeatedfreeze-thawcycles.
|
| Buffer | Lyophilizedfroma0.2μmfilteredsolutioninPBSwithBSAasacarrierprotein. |
| Purity | >95%,bySDS-PAGEvisualizedwithSilverStainingandquantitativedensitometrybyCoomassie®BlueStaining. |
| ReconstitutionInstructions | Reconstituteat100μg/mLinPBScontainingatleast0.1%humanorbovineserumalbumin. |
Notes
ThisproductisproducedbyandshipsfromR&DSystems,Inc.,aBio-Technebrand.
AlternateNamesforRecombinantHumanIL-6(HEK293-expressed)Protein
- Bcellstimulatoryfactor-2
- B-celldifferentiationfactor
- BSF2
- BSF-2
- BSF2CTLdifferentiationfactor
- CDF
- HGFHSFIFNB2Hybridomagrowthfactor
- IFNB2
- IFN-beta-2
- IL6
- IL-6
- IL-6B-cellstimulatoryfactor2
- Interferonbeta-2
- interleukin6(interferon,beta2)
- interleukinBSF-2
- interleukin-6
- MGI-2A
Background
Interleukin-6(IL-6)isapleiotropic,alpha-helical,22-28kDaphosphorylatedandvariablyglycosylatedcytokinethatplaysimportantrolesintheacutephasereaction,inflammation,hematopoiesis,bonemetabolism,andcancerprogression(1-5).MaturehumanIL-6is183aminoacids(aa)inlengthandshares39%aasequenceidentitywithmouseandratIL-6(6).Alternativesplicinggeneratesseveralisoformswithinternaldeletions,someofwhichexhibitantagoNISTicproperties(7-10).IL-6inducessignalingthroughacellsurfaceheterodimericreceptorcomplexcomposedofaligandbindingsubunit(IL-6Ralpha)andasignaltransducingsubunit(gp130).IL-6bindstoIL-6Ralpha,triggeringIL-6Ralphaassociationwithgp130andgp130dimerization(11).gp130isalsoacomponentofthereceptorsforCLC,CNTF,CT-1,IL-11,IL-27,LIF,andOSM(12).SolubleformsofIL-6Ralphaaregeneratedbybothalternativesplicingandproteolyticcleavage(5).Inamechanismknownastrans-signaling,complexesofsolubleIL-6andIL-6Ralphaelicitresponsesfromgp130-expressingcellsthatlackcellsurfaceIL-6Ralpha(5).Trans-signalingenablesawiderrangeofcelltypestorespondtoIL-6,astheexpressionofgp130isubiquitous,whilethatofIL-6Ralphaispredominantlyrestrictedtohepatocytes,monocytes,andrestinglymphocytes(2,5).Solublespliceformsofgp130blocktrans-signalingfromIL-6/IL-6Ralphabutnotfromothercytokinesthatusegp130asaco-receptor(5,13).IL-6,alongwithTNF-alphaandIL-1,drivestheacuteinflammatoryresponseandthetransitionfromacuteinflammationtoeitheracquiredimmunityorchronicinflammatorydisease(1-5).Whendysregulated,itcontributestochronicinflammationinobesity,insulinresistance,inflammatoryboweldisease,arthritis,sepsis,andatherosclerosis(1,2,5).IL-6canalsofunctionasananti-inflammatorymolecule,asinskeletalmusclewhereitissecretedinresponsetoexercise(2).Inaddition,itenhanceshematopoieticstemcellproliferationandthedifferentiationofTh17cells,memoryBcells,andplasmacells(1,14).
- Mansell,A.andB.J.Jenkins(2013)CytokineGrowthFactorRev.24:249.
- Schuett,H.etal.(2009)Thromb.Haemost.102:215.
- Erta,M.etal.(2012)Int.J.Biol.Sci.8:1254.
- Garbers,C.etal.(2012)CytokineGrowthFactorRev.23:85.
- Mihara,M.etal.(2012)Clin.Sci.(Lond.)122:143.
- Hirano,T.etal.(1986)Nature324:73.
- Kestler,D.P.etal.(1995)Blood86:4559.
- Kestler,D.P.etal.(1999)Am.J.Hematol.61:169.
- Bihl,M.P.etal.(2002)Am.J.Respir.CellMol.Biol.27:48.
- Alberti,L.etal.(2005)CancerRes.65:2.
- Murakami,M.etal.(1993)Science260:1808.
- Muller-Newen,G.(2003)Sci.STKE2003:PE40.
- Mitsuyama,K.etal.(2006)Clin.Exp.Immunol.143:125.
- Cerutti,A.etal.(1998)J.Immunol.160:2145.
CustomersWhoViewedThisItemAlsoViewed...
Novus Biologicals
美国Novus Biologicals公司是一家抗体专业公司,生产用于研究的单克隆和多克隆抗体,包含5万多种一抗和近1000种二抗,产品涉及神经生物学,细胞凋亡,肿瘤,DNA修复,干细胞标记,信号转导等多个研究方向。多年的抗体生产服务经验,使novus得以引领生物科学发展趋势,并可随时为生物科研工作者提供最新和最广泛的产品。Novus的愿景是通过开发和销售在前沿科学的独特产品来推动科学发现。Novus组织了商业化机制,致力于为生物研究界提供独特的生物材料。Novus还持续关注科学趋势,并为新的研究提供必要的材料。Novus的产品广泛使用于机构和商业研究,并在推动生物学研究中起着重要的。
Novus Biologicals is a biotech company based in Littleton, Colorado, USA with offices in San Diego, California, Oakville, ON, Canada and the Cambridge Science Park in Cambridge, UK.[1] The company develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Novus, like many others companies such as Abcam, Covance, Proteintech Group, EnCor Biotechnology and Millipore Corporation, arose to answer a call for research grade antibodies for the scientific market.Founded by Karen Padgett in 1996, Novus Biologicals has sought to partner with leading scientific researchers and third-party providers to develop an extensive range of more than 180,000 products.[2] The main products are antibodies, proteins, peptides, RNAi, cell lysates, isotype controls, slides, and kits. Padgett is company president and CEO, and has been active both in the academic and local Colorado communities.
In 2008, Novus became a limited liability company when Mainsail Partners invested in the company.[4] Novus Biologicals has reported double digit revenue growth every year since its inception, has been selected six years in a row to the Inc. (magazine) 5000 fastest-growing private companies in America,[5] and was on the 2009 list of Colorado Companies to Watch.[6]In 2014 major antibody and reagent supplier Bio-Techne, acquired Novus Biologicals for $60 million.[7] The acquisition was meant to provide scientists and doctors a broader selection of products in one location.
产品列表:
Novus-Biologicals
SP4385P
MC1 Receptor Antibody
0.05mg
Novus-Biologicals
PA184X
Defensin beta 3 Protein
0.02mg
Novus-Biologicals
NSB998
PKA 2 beta [phospho Ser114] Antibody
0.1ml
Novus-Biologicals
NSB992
cAMP Protein Kinase Catalytic subunit beta [phospho Ser338] Antibody
0.05ml
Novus-Biologicals
NSB988
cAMP Protein Kinase Catalytic subunit alpha [phospho Thr197] Antibody
0.1ml
Novus-Biologicals
NSB979
PKC theta [phospho Ser695] Antibody
0.1ml
Novus-Biologicals
NSB978
PKC eta [phospho Ser674] Antibody
0.1ml
Novus-Biologicals
NSB977
PKC epsilon [phospho Ser729] Antibody
0.1ml
Novus-Biologicals
NSB976
PKC delta [phospho Ser664] Antibody
0.1ml
Novus-Biologicals
NSB975
PKC gamma [phospho Thr674] Antibody
0.1ml
Novus-Biologicals
NSB970
PKC theta [phospho Ser676] Antibody
0.1ml
Novus-Biologicals
NSB969
PKC eta [phospho Thr655] Antibody
0.1ml
Novus-Biologicals
NSB968
PKC iota [phospho Thr555/Thr563] Antibody
0.1ml
Novus-Biologicals
NSB966
PKC delta [phospho Ser645] Antibody
0.1ml
Novus-Biologicals
NSB965
PKC gamma [phospho Thr655] Antibody
0.1ml
Novus-Biologicals
NSB964
PKC beta [phospho Thr641] Antibody
0.1ml
Novus-Biologicals
NSB963
PKC beta [phospho Thr642] Antibody
0.1ml
Novus-Biologicals
NSB962
PKC alpha [phospho Thr638] Antibody
0.1ml
Novus-Biologicals
NSB961
PKC mu [phospho Ser738/Ser742] Antibody
0.1ml
Novus-Biologicals
NSB960
PKC theta [phospho Thr538] Antibody
0.1ml
Novus-Biologicals
NSB956
PKC gamma [phospho Thr514] Antibody
0.1ml
Novus-Biologicals
NSB955
PKC beta [phospho Thr500] Antibody
0.1ml
Novus-Biologicals
NSB948
GATA4 [phospho Ser105] Antibody
0.1ml
Novus-Biologicals
NSB944
NFAT1 [phospho Ser54] Antibody
0.1ml
Novus-Biologicals
NSB942
PAK1/2/3 [phospho Thr423] Antibody
0.1ml
Novus-Biologicals
NSB940
PAK1/2/3 [phospho Ser141] Antibody
0.1ml
Novus-Biologicals
NSB928
RSK1 [phospho Ser380] Antibody
0.1ml
Novus-Biologicals
NSB926
RSK1 [phospho Ser363] Antibody
0.1ml
Novus-Biologicals
NSB924
RSK1 [phospho Ser221] Antibody
0.1ml
Novus-Biologicals
NSB923
RPS6 [phospho Ser244/Ser247] Antibody
0.1ml
Novus-Biologicals
NSB922
RPS6 [phospho Ser235/Ser236] Antibody
0.1ml
Novus-Biologicals
NSB921
RPS6 [phospho Ser236] Antibody
0.1ml
Novus-Biologicals
NSB918
S6K [phospho Thr229] Antibody
0.1ml
Novus-Biologicals
NSB912
Src [phospho Tyr522] Antibody
0.1ml
Novus-Biologicals
NSB910
Hck [phospho Tyr207/Ser211] Antibody
0.1ml
Novus-Biologicals
NSB909
DAB1 [phospho Ser491] Antibody
0.1ml
Novus-Biologicals
NSB908
DAB1 [phospho Tyr220] Antibody
0.1ml
Novus-Biologicals
NSB906
DAB1 [phospho Tyr198] Antibody
0.1ml
Novus-Biologicals
NSB896
Met (c-Met) [phospho Tyr1365] Antibody
0.1ml
Novus-Biologicals
NSB892
Met (c-Met) [phospho Tyr1349] Antibody
0.1ml













![Western Blot: STAT3 Antibody (9D8) [NBP2-22471] - Human breast cancer cell MDA-MB-231 was treated with carboplatin for 72 hours and the expression of p-Stat3 at Y705 and total Stat3 were detected by western blot. From verified customer review.](http://images.novusbio.com/images2/STAT3-Antibody-(9D8)-Western-Blot-NBP2-22471-img0023.jpg)
![Immunocytochemistry/Immunofluorescence: STAT3 Antibody (9D8) [NBP2-22471] - Analysis of STAT3 using anti-STAT3 (9D8) monoclonal antibody (shown in green) in HeLa cells. Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature. Cells were then blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with a mouse monoclonal antibody recognizing STAT3, at a dilution of 1:100 for at least 1 hour at room temperature. Cells were then washed with PBS and incubated with DyLight 488 goat-anti-mouse secondary antibody at a dilution of 1:400 for 30 minutes at room temperature. Nuclei (blue) were stained with Hoechst 33342 dye.](http://images.novusbio.com/images2/STAT3-Antibody-(9D8)-Immunocytochemistry-Immunofluorescence-NBP2-22471-img0016.jpg)
![Immunohistochemistry-Paraffin: STAT3 Antibody (9D8) [NBP2-22471] - Biopsies of normal and cancer tissues.](http://images.novusbio.com/images2/STAT3-Antibody-(9D8)-Immunohistochemistry-Paraffin-NBP2-22471-img0017.jpg)

![Western Blot: LIF Antibody (39N7D10) [NBP2-27406] - LIF expression in human primary T-cells and cancer cell lines: Jurkat and K562. Image from verified customer review.](http://images.novusbio.com/images2/LIF-Antibody-(39N7D10)-Western-Blot-NBP2-27406-img0009.jpg)
![Immunohistochemistry-Paraffin: LIF Antibody (39N7D10) [NBP2-27406] - Tissue section of mouse brain using 5 ug/ml concentration of LIF antibody (clone 39N7D10).](http://images.novusbio.com/images2/LIF-Antibody-(39N7D10)-Immunohistochemistry-Paraffin-NBP2-27406-img0008.jpg)
![Western Blot: LIF Antibody (39N7D10) [NBP2-27406] - WB validation of LIF antibody (clone 39N7D10) on (A) full-length recombinant Lif protein, (B) mouse spleen lysate and (C) human spleen lysate. 3 ug/mL concentration of primary antibody, Goat anti-rat IgG HRP secondary antibody and PicoTect ECL substrate solution were used for this assay.](http://images.novusbio.com/images2/LIF-Antibody-(39N7D10)-Western-Blot-NBP2-27406-img0001.jpg)
![Western Blot: NFkB p105/p50 Antibody (2J10D7) [NB100-56583] - Analysis of p50 in HeLa lysate in the A) absence and B) presence of immunizing peptide using p50 antibody at 5 ug/ml.](http://images.novusbio.com/images2/NFkB-p105-p50-Antibody-(2J10D7)-Western-Blot-NB100-56583-img0004.jpg)
![Immunohistochemistry-Paraffin: NFkB p105/p50 Antibody (2J10D7) [NB100-56583] - IHC-P of rabbit aorta using NB100-56583. Secondary antibody: anti-mouse histofine ( Nisherei Bioscience Inc. ref: 414131F). Development: DAB (Dako ref: K346811-2) and counterstained with Hematoxylin. Submitted via verified customer review](http://images.novusbio.com/images2/NFkB-p105-p50-Antibody-(2J10D7)-Immunohistochemistry-Paraffin-NB100-56583-img0009.jpg)
![Flow Cytometry: NFkB p105/p50 Antibody (2J10D7) [NB100-56583] - An intracellular stain was performed on U937 cells with NFkB p105/p50 [2J10D7] Antibody NB100-56583C (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to DyLight 650.](http://images.novusbio.com/images2/NFkB-p105-p50-Antibody-(2J10D7)-Flow-Cytometry-NB100-56583-img0008.jpg)


![Western Blot: TLR4 Antibody (76B357.1) [NB100-56566] - Analysis using 2 ug/ml on (A) human intestine and 6 ug/ml on (B) mouse intestine and C) rat intestine lysate.](http://images.novusbio.com/images2/TLR4-Antibody-(76B357.1)-Western-Blot-NB100-56566-img0018.jpg)
![Immunohistochemistry-Paraffin: TLR4 Antibody (76B357.1) [NB100-56566] - Human skin stained with at 5 ug/ml, peroxidase-conjugate and DAB chromogen. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM sodium citrate buffer, pH 6.0 for 10-20 min followed by cooling at RT for 20 min.](http://images.novusbio.com/images2/TLR4-Antibody-(76B357.1)-Immunohistochemistry-Paraffin-NB100-56566-img0007.jpg)
![Flow (Intracellular): TLR4 Antibody (76B357.1) [NB100-56566] - Analysis using PE conjugate of NBP2-27149. An intracellular stain was performed on Jurkat cells with TLR4 antibody (76B357.1) NBP2-27149PE (blue) and an isotype control MAB004 (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to phycoerythrin.](http://images.novusbio.com/images2/TLR4-Antibody-(76B357.1)-Flow-(Intracellular)-NB100-56566-img0025.jpg)
